An interventional study of Check Symptoms and Uncheck Symptoms in Meningioma, sponsored by Carnegie Mellon University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-08-02.
Sponsored by Carnegie Mellon University · Not applicable, Interventional, and Screening
Prevention and early detection of medical problems can greatly reduce health care costs, yet time and again, people avoid or ignore services that could help detect medical problems early enough to prevent or reduce the severity of potential problems. The investigators seek to understand whether the elicitation of symptom admission by patients can predict people's perceived risk of the medical condition and voluntary pursuit of medical information.
We will present individuals with medically accurate information about a medical condition and measure people's perceptions of their own likelihood to having that medical condition. This will include an opportunity for people to pursue more information by directing them to a website that features more information about the condition. The initial information provision will vary slightly in presentation (method of eliciting symptoms will vary), and the rate at which individuals visit the subsequent medical website to receive more information will be recorded as a measure of information seeking behavior. Rates will be compared across symptom elicitation conditions to determine which formats are most effective at encouraging information seeking about health issues. No personally identifying information will be collected, and all results will be reported in aggregate. Critically, no deception will be used: Participants will only be provided with information that is as accurate as possible (given existing knowledge in the health/medical fields).
226 studies on the registry are indexed under Meningioma; 87 are open to participants now.
This study's enrollment of 305 is above the median of 40 across 161 interventional studies indexed under Meningioma.
Browse Meningioma studies →Carnegie Mellon University is the lead sponsor of 46 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Participants are asked to check the symptoms that they have experienced in the last 6 weeks.
Other: Check Symptoms · Other: Experienced
Participants are asked to un-check the symptoms that they have experienced in the last 6 weeks.
Other: Uncheck Symptoms · Other: Experienced
Participants are asked to check the symptoms that they have NOT experienced in the last 6 weeks.
Other: Check Symptoms · Other: Not Experienced
Participants are asked to un-check the symptoms that they have NOT experienced in the last 6 weeks.
Other: Uncheck Symptoms · Other: Not Experienced
Symptoms are "Checked"
Symptoms are "Un-checked"
Focus of instructions is on symptoms the participant has experienced
Focus of instructions is on symptoms the participant has NOT experienced
Number of symptoms
The number of symptoms checked off by participants
Time frame: 1 day
Risk of meningioma
Self-reported perceived risk of meningioma
Time frame: 1 day
Information pursuit
Binary measure of whether participants click to receive information about meningioma
Time frame: 1 day
Funding allocation
Hypothetical federal funding allocation to meningioma
Time frame: 1 day
Risk of serious disease
Perceived risk of having any serious disease
Time frame: 1 day
This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Carnegie Mellon University